Low FODMAP diet improves leaky gut in study

Researchers examine how food affects intestinal permeability

11:00 AM

Author | Sam Page

light pink cells of stomach lining with blue and yellow and purple cells floating around
Getty Images

In a study, patients with irritable bowel syndrome with diarrhea, or IBS-D, who went on a low FODMAP diet saw an improvement of colonic barrier dysfunction, commonly known as “leaky gut.” 

The results, published in Gastroenterology, represent the first evidence of low FODMAP’s potential ability to improve intestinal permeability and mast cell activation in patients with IBS. 

“Diet and microbiome have been believed to be related to leaky gut, but the reasons why were not well understood,” said Prashant Singh, MBBS, Michigan Medicine gastroenterologist and senior author on the paper. 

“This research illuminates the mechanism of how food can interact with gut microbiome and gut immune system to influence colonic barrier dysfunction—and validates the low FODMAP diet as a treatment option that not only improves symptoms but underlying dysfunction in IBS.”  

The low FODMAP diet is a proven intervention for patients with IBS.

Most IBS sufferers report food-triggered symptoms and prefer dietary inventions to pharmacotherapy. 

Leaky gut refers to symptoms caused by increased permeability of the intestinal lining.

This permeability is thought to have a variety of negative consequences, including the dissemination of bacterial toxins and products as well as sensitization of local nerves which can cause pain in IBS. 

Researchers studied human patients to test the potential of low FODMAP to address leaky gut, while mice treated with stool from these patients were used to investigate the mechanisms of how diet potentially improves the colonic barrier.  

Forty-eight patients with IBS-D (irritable bowel syndrome with diarrhea) were put on a four-week low FODMAP diet (restriction phase) and provided with the low FODMAP meals for the study duration.

Of the 42 participants to complete the study, 34 responded to the low FODMAP diet, all of whom experienced lessened diarrhea and abdominal pain.

Prior studies have shown that patients with IBS-D have increased number of mast cell (type of inflammatory cell in colon lining), and leaky gut.

Studies have shown that mast cells are also more likely to be activated in IBS-D.

In this study, barrier function, and mast cell activation was assessed in a variety of ways before and after the four-week period. 

Researchers found that in addition to improvement in leaky gut, low FODMAP also reduced the number and activation of mast cells in the colon lining in these patients.

Researchers also worked toward an explanation of how low FODMAP improves leaky gut (and how a diet high in FODMAP foods can contribute to barrier dysfunction.)

Lipopolysaccharides are molecules derived from gut microbiome that can cause immune-system responses when they escape the gut.

In this latest study, an analysis using mice, researchers showed that high FODMAP diet in IBS-D patients increases fecal LPS levels to activate mast cells which in turn make the barrier leakier.

Given these results, researchers recommend that providers consider mast cell stabilizers in addition to a low FODMAP diet—or as an alternative to the low FODMAP diet when it is contraindicated.

“Our study shows diet is not a quick fix—it’s a real solution for some patients with IBS,” Singh said.

The authors hope future studies will include a larger sample size, specifically of patients who do not respond to low FODMAP diet, and a variety of IBS types besides IBS-D.

Additional authors: Jun Gao, Allen A. Lee, Shabnam Abtahi, Jerrold R. Turner, Madhusudan Grover, Alexander Schmidt, Thomas M. Schmidt, Judy W. Nee, Johanna Iturrino, Anthony Lembo, William D. Chey, John W. Wiley

Funding/disclosures: NIDDK K23DK129327

Paper cited: “Low FODMAP diet improves colonic barrier function and mast cell activation in patients with IBS-D: A mechanistic trial,” Gastroenterology. 10.1053/j.gastro.2025.07.016 

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.


More Articles About:

Irritable Bowel Syndrome (IBS) Inflammatory Bowel Disease (IBD) Gastroenterology Digestive (GI) Conditions Digestive Diseases Digestive Health All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Prashant Singh

Prashant Singh, MBBS

Assistant Professor

Related

Health Lab

The Low FODMAP Diet: A 'Liberating' Route to IBS Relief

An elimination diet designed to identify trigger foods can help curb gut discomfort. A Michigan Medicine gastroenterologist explains how it works.
Ingredients for a low FODMAP recipe
Health Lab

5 Easy, Low FODMAP Diet Recipes for Every Meal

Low FODMAP recipes to help you stick to your elimination diet for IBS. Check out these easy low FODMAP diet recipes for breakfast, lunch, and dinner ideas.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

close up of cells blue purple pink
Health Lab

Researchers create new path to target hard-to-drug prostate cancer protein

University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.
team standing around person using virtual reality headset
Health Lab

How new care models, within a new building launch, are helping optimize patient care

New care models in a new building opening at Michigan Medicine is helping to optimize patient care.
Health Lab

Path forward for glioblastoma treatment

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
lights scattered all over blue screen connected
Health Lab

Studying neurons using neurons

Labs at the University of Michigan Medical School are exploring a new technology that leverages the biological capabilities of human neurons for artificial intelligence.
woman looking at screen in office clinical area
Health Lab

How AI is helping emergency physicians learn from their patients

How the “Tell Me What Happens Next” initiative is being used by the Department of Emergency Medicine’s new Division of Clinical Informatics using artificial intelligence.
baby with hearing aid on ear looking from side view with blue pacifier in mouth
Health Lab

Research may help better predict outcomes in kids with congenital cytomegalovirus

Two new studies may help researchers and clinicians better understand congenital cytomegalovirus (CMV), the most common infectious cause of birth defects and a leading cause of non-genetic hearing loss in children.